Cargando…

Orbital involvement by NUT midline carcinoma: new presentation and encouraging outcome managed by radiotherapy combined with tyrosine kinase inhibitor: a case report

BACKGROUND: NUT midline carcinoma (NMC) is a poorly differentiated squamous cancer with a median survival at less than 7 months. NMC is resistant to conventional chemotherapies and characterized by rearrangement of the NUT gene. CASE PRESENTATION: Here, we described a patient who initially presented...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chai, Peiwei, Zhou, Chuandi, Jia, Renbing, Wang, Yefei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6942267/ https://www.ncbi.nlm.nih.gov/pubmed/31900183 http://dx.doi.org/10.1186/s13000-019-0922-1

Ejemplares similares

Clinical characteristics and mutation Spectrum of NF1 in 12 Chinese families with orbital/periorbital plexiform Neurofibromatosis type 1
por: Chai, Peiwei, et al.
Publicado: (2019)

Comprehensive circular RNA expression profiling with associated ceRNA network in orbital venous malformation
por: Yu, Jie, et al.
Publicado: (2022)

Systematic Kinase Inhibitor Profiling Identifies CDK9 as a Synthetic Lethal Target in NUT Midline Carcinoma
por: Brägelmann, Johannes, et al.
Publicado: (2017)

Comparative drug screening in NUT midline carcinoma
por: Beesley, A H, et al.
Publicado: (2014)

Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma
por: Yang, Jie, et al.
Publicado: (2019)

Quality of Life (QoL) and Psychosocial Outcomes in Adult Survivors of Unilateral Retinoblastoma (RB) in China
por: Feng, Yiyi, et al.
Publicado: (2020)

NUT midline carcinoma of the head and neck: current perspectives
por: Napolitano, M, et al.
Publicado: (2019)

Clinicopathological and molecular characterizations of pulmonary NUT midline carcinoma
por: Xie, Mian, et al.
Publicado: (2021)

How Much Can We Bet on Activity of BET Inhibitors Beyond NUT–Midline Carcinoma?
por: Martin-Romano, Patricia, et al.
Publicado: (2019)

SAT-125 A Tough NUT (Midline Carcinoma) to Crack
por: Lavelle, Kristen, et al.
Publicado: (2020)

Prolonged Survival of NUT Midline Carcinoma and Current Approaches to Treatment
por: Kaplan, Henry G, et al.
Publicado: (2023)

Deciphering the Role of microRNAs in BRD4-NUT Fusion Gene Induced NUT Midline Carcinoma
por: Pathak, Ekta, et al.
Publicado: (2017)

Case Report: Favorable Response to the Tyrosine Kinase Inhibitor Apatinib in Recurrent Merkel Cell Carcinoma
por: Feng, Yiyi, et al.
Publicado: (2021)

NUT midline carcinoma as a primary lung tumor treated with anlotinib combined with palliative radiotherapy: a case report
por: Jiang, Jin, et al.
Publicado: (2022)

Usefulness of Nuclear Protein in Testis (NUT) Immunohistochemistry in the Cytodiagnosis of NUT Midline Carcinoma: A Brief Case Report
por: Park, Heae Surng, et al.
Publicado: (2014)

Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma
por: Lee, J.-K., et al.
Publicado: (2017)

Alpha–fetoprotein elevation in NUT midline carcinoma: a case report
por: D’Ambrosio, Lorenzo, et al.
Publicado: (2017)

Case Report and Literature Review: Primary Pulmonary NUT-Midline Carcinoma
por: Zhang, Yunxiang, et al.
Publicado: (2021)

Contemporary update of overall prognosis and nomogram to predict individualized survival for Chinese patients with eyelid sebaceous carcinoma
por: Zhou, Chuandi, et al.
Publicado: (2018)

Impressive Response to Dose-Dense Chemotherapy in a Patient with NUT Midline Carcinoma
por: Maur, Michela, et al.
Publicado: (2015)

NUT midline carcinoma in a young pregnant female: a case report
por: Joel, Sebastian, et al.
Publicado: (2020)

Clinical features, treatment, and survival outcome of primary pulmonary NUT midline carcinoma
por: Xie, Xiao-Hong, et al.
Publicado: (2020)

Successful treatment of a case with NUT midline carcinoma in the larynx and review of the literature
por: Zhang, Hai, et al.
Publicado: (2019)

Clinicopathological Analysis of Five Cases of NUT Midline Carcinoma, including One with the Gingiva
por: Zhou, Luting, et al.
Publicado: (2020)

NUT Midline Carcinoma: A Rare Solid Tumour Characterized by Chromosome Rearrangement
por: Zhang, Huan, et al.
Publicado: (2022)

Midline carcinoma with t(15;19) and BRD4-NUT fusion oncogene in a 30-year-old female with response to docetaxel and radiotherapy
por: Engleson, Jens, et al.
Publicado: (2006)

Nomogram for Preoperative Estimation of Orbit Invasion Risk in Periocular Squamous Cell Carcinoma
por: Xie, Minyue, et al.
Publicado: (2020)

Genetic modifiers of the BRD4-NUT dependency of NUT midline carcinoma uncovers a synergism between BETis and CDK4/6is
por: Liao, Sida, et al.
Publicado: (2018)

NUT midline carcinoma mimicking a germ cell tumor: a case report
por: Harada, Yohei, et al.
Publicado: (2016)

Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma
por: Zhang, Xin, et al.
Publicado: (2020)

Germinoma with Involvement of Midline and Off-Midline Intracranial Structures
por: Loto, Monica Graciela, et al.
Publicado: (2014)

Dynamic chromosomal tuning of a novel GAU1 lncing driver at chr12p13.32 accelerates tumorigenesis
por: Chai, Peiwei, et al.
Publicado: (2018)

LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter
por: Ni, Hongyan, et al.
Publicado: (2020)

Sinonasal NUT-Midline Carcinoma – A Multimodality Approach to Diagnosis, Staging and Post-Surgical Restaging
por: Shaikh, Faiq, et al.
Publicado: (2015)

Novel insights on m(6)A RNA methylation in tumorigenesis: a double-edged sword
por: Wang, Shaoyun, et al.
Publicado: (2018)

Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation
por: Shi, Hanhan, et al.
Publicado: (2020)

A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma
por: Stirnweiss, A, et al.
Publicado: (2015)

Cytological Features of a Variant NUT Midline Carcinoma of the Lung Harboring the NSD3-NUT Fusion Gene: A Case Report and Literature Review
por: Kuroda, Shiho, et al.
Publicado: (2015)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5b0sj4beol8ujbe7u61086aj3m